American Society of Clinical Oncology

SHERPA: White

People

  1. Drilon
    Drilon
  2. Arcila
    Arcila
  3. Berger
    Berger
  4. Gounder
    Gounder
  5. Kris
    Kris
  6. Ladanyi
    Ladanyi
  7. Harding
    Harding
  8. Iasonos
    Iasonos
  9. Li
    Li
  10. Riely
    Riely

Groups

  1. Department of Medicine (13)
  2. Early Drug Development Service (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (5)
  7. Epidemiology and Biostatistics (4)
  8. Tow Center for Developmental Oncology (TCDO) (4)
  9. Sarcoma Service (3)
  10. Biostatistics Service (2)
Search Within
  1. "David Hyman"
  2. "Meeting abstract"
  3. "Alexander Drilon"
Formats
  1. Meeting Abstract (13)
Groups
  1. Department of Medicine (13)
  2. Early Drug Development Service (13)
  3. Solid Tumor Oncology Division (13)
  4. Thoracic Oncology (13)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Alexander Drilon (13)
  2. David Hyman (13)
  3. Marc Ladanyi (4)
  4. Maria Arcila (4)
  5. Michael Berger (4)
  6. Ahmet Zehir (3)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (2)
  4. 2017 (1)
  5. 2016 (2)
  6. 2015 (4)
Publications
  1. Journal of Clinical Oncology (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Meeting Abstract

    Berlin, J.; Hong, D. S.; Deeken, J. F.; Boni, V.; Oh, D. Y.; Patel, J. D.; Nanda, S.; Brega, N.; Childs, B. H.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics of NRG1 fusion-positive cancers: A single-institution study
    Meeting Abstract

    Schram, A. M.; Benayed, R.; Somwar, R.; Rekhtman, N.; Arcila, M. E.; Ladanyi, M.; Hyman, D. M.; Drilon, A. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in adult TRK fusion cancer patients
    Meeting Abstract

    Hong, D. S.; Kummar, S.; Farago, A. F.; Lassen, U. N.; Berlin, J.; Schilder, R. J.; McDermott, R. S.; Patel, J. D.; Dowlati, A.; Doebele, R. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1 fusion-positive non-small cell lung cancer (TRIDENT-1 study)
    Meeting Abstract

    Cho, B. C.; Drilon, A. E.; Doebele, R. C.; Kim, D. W.; Lin, J. J.; Lee, J.; Ahn, M. J.; Zhu, V. W.; Ejadi, S.; Camidge, D. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers
    Meeting Abstract

    Hyman, D. M.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Farago, A. F.; Pappo, A. S.; Demetri, G. D.; El-Deiry, W. S.; Lassen, U. N.; Dowlati, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II basket study of the oral TRK inhibitor LOXO-101 in adult subjects with NTRK fusion-positive tumors
    Meeting Abstract

    Drilon, A. E.; Hong, D. S.; Cruickshank, S.; Deegan, M.; Ku, N.; Hyman, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save